CAS : 59-05-2
Packing : 25kg/Drum
Methotrexate is used as a disease-modifying treatment for some autoimmune diseases, including rheumatoid arthritis, juvenile dermatomyositis, psoriasis, psoriatic arthritis, lupus, sarcoidosis, Crohn's disease (although a recent review has raised the point that it is fairly underused in Crohn's disease), eczema and many forms of vasculitis. Although originally designed as a chemotherapy drug (using high doses), in low doses, methotrexate is a generally safe and well tolerated drug in the treatment of certain autoimmune diseases. Because of its effectiveness, low-dose methotrexate is now first-line therapy for the treatment of rheumatoid arthritis. Weekly doses are beneficial for 12 to 52 weeks duration therapy, although discontinuation rates are as high as 16% due to adverse effects. Although methotrexate for autoimmune diseases is taken in lower doses than it is for cancer, side effects such as hair loss, nausea, headaches, and skin pigmentation are still common. Use of low doses of methotrexate together with NSAIDS such as aspirin or paracetamol is relatively safe in people being treated for rheumatoid arthritis, if adequate monitoring is done.
Function
1.It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.
2.It is used for include breast cancer, leukemia, lung cancer, lymphoma, and osteosarcoma.Types of autoimmune diseases
3.It is used for include psoriasis, rheumatoid arthritis, and Crohn's disease.
Application
Methotrexate is used as a disease-modifying treatment for some autoimmune diseases, including rheumatoid arthritis, juvenile dermatomyositis, psoriasis, psoriatic arthritis, lupus, sarcoidosis, Crohn's disease (although a recent review has raised the point that it is fairly underused in Crohn's disease), eczema and many forms of vasculitis. Although originally designed as a chemotherapy drug (using high doses), in low doses, methotrexate is a generally safe and well tolerated drug in the treatment of certain autoimmune diseases.
Supplier: Folic acid (cas no.:59-30-3), calcium folinate, calcium levofolinate, phytosterols, methotrexate, methotrexate sodium, cytarabine, alfuzosine hcl, omeprazole magnesium, esomeprazole magnesium & some with fda, cos, gmp
Buyer: Formic acid, acetone, hydrochloric acid
Supplier: Paclitaxel, docetaxel, side chain of paclitaxel and docetaxel, imatinib, gefitinib, erlotinib, dasatinib, lapatinib, sunitinib, sorafenib, pemetrexed, anastrozole, gemcitabine, capecitabine, fluderabine, letrozole, dorzolamide, tamsolusin, melphalan, chlorombucil, irrinotecan, gentamycin b, neomycin b, arbekacin, methotrexate, cytazabine, idebenone, 5-aminolevulinic acid
Supplier: Main product catalogue, atracurium besilate bp2002, anatrozole 99.5%, betamethasone sodium phosphate usp28/ bp2003, betamethasone valerate usp28/bp2003, busulfan usp26, carvedilol ep5 edmf, clomiphene citrate usp28, calcium levofolinate 99%, cytarabine usp29, clobetasol propionate bp2000, cyclophosphamide usp28, estradiol valerate usp28, estradiol benzoate bp2000/usp28, estriol bp2000 usp26, estrone usp29, estradiol usp26, etoposide usp28, flutamide usp26, finasteride usp28, irinotecan hcl >99.0%, letrozole 99.3%, leucovorin calcium usp28, lomustine bp2000, methotrexate usp28, methotrexate disodium 99.5%, p-n-methylaminobenzoylglutamic acid zinc salt 80.0%, mesna ep5, mafenide acetate usp27 gmp, norcantharidinum cp2000, nandrlone bp2000/usp28, nandrlone phenylpropionate bp2000/usp28, ondansetron hyd
